Evaluation of the current trend of nalidixic acid susceptibility in typhoidal Salmonellae; a marker of therapeutic failure for the fluoroquinolones
,
Abstract
Background and Objectives: Typhoid is a major health problem faced by the developing countries like Pakistan. More than 20 million cases are reported annually worldwide. Currently fluoroquinolones are the drugs of choice to treat typhoid fever. In vivo resistance to fluoroquinolones leading to therapeutic failure is developing rapidly and is becoming a major concern for the clinicians. The objective of this study was to determine the sensitivity pattern of Nalidixic acid over the last four years
Material and Methods: A descriptive cross sectional study was carried out at the Microbiology Department of the Army Medical College, National University of Sciences and Technology, Rawalpindi from January 2006 to December 2009. All the isolates were dealt with standard microbiological procedures. The antimicrobial sensitivity of Nalidixic acid and Ciprofloxacin was determined using Kirby-Bauer disc diffusion method as per the guidelines of Clinical and Laboratory Standard Institute (CLSI).
Results: Out of 240 isolates, 111 were Salmonella typhi and 129 were Salmonella paratyphi A. The resistance of the typhoidal Salmonella to Nalidixic acid has reached significant levels and it seems only a matter of time when hundred percent resistance will be encountered. All isolates were sensitive to Ciprofloxacin on disc diffusion method.
Conclusion: Resistance to Nalidixic acid predicting therapeutic failure with fluoroquinolones is on a steady rise.
Papagrigorakis MJ, Yapijakis C, Synodinos PN, Baziotopoulou-Valavani E. DNA examination of ancient dental pulp incriminates typhoid fever as a probable cause of the Plague of Athens. Int J Infect Dis 2006; 10: 206-214.
Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull WHO 2004; 82: 346-353.
Ochiai RL, Wang XY, von Seidlein L, Yang J, Bhutta ZA, Bhattacharya SK, et al. Salmonella Paratyphi A rates in Asia. Emerg Infect Dis 2005; 11. ISSN: 1080-6040.
Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ.Typhoid fever. N Engl J Med 2002; 347: 1182-84. ISSN:0028-4793.
Ahmad R, Mahmood A, Zaidi S. Ciprofloxacin treatment failure in typhoid fever case,Pakistan. East Mediterr Health J 2005; 11:1621-1622.
Asna SM, Haq JA, Rahman M. Nalidixic acid- resistant Salmonellaenterica serovar typhi with decreased susceptibility to ciprofloxacin caused treatment failure: a report from Bangladesh. Jpn J Infect Dis 2003; 56: 32-33.
Ouabdesselam S, Tankovic J, Soussy CJ. Quinolone resistance mutations in the gyrA gene of clinical isolates of Salmonella. Microb Drug Resist 1996; 2: 299-302.
Hakanen A, Kotilainen P, Jalava J, Sutonen A, Huovinen P. Detection of decrease fluroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol 1999 November; 37: 3572-3577.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 19th informational supplement M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA. 2009.
Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11:1038-1044.
Tankhilwala SS, Agarwal G, Jalgaonkar SV. An unusually high occurrence of Salmonella enterica serotype paratyphi A in patients with enteric fever. Ind J Med Res 2003; 117: 10-12.
Lynch MF, Blanton EM, Bulens S, Polyak C, Vojdani J, Stevenson J, et al. Typhoid fever in the United States,1999-2006. JAMA 2009; 302: 859-865.
Aggarwal A, Singh A, Oberoi A. A three-year retrospective study on the prevalence, drug susceptibility pattern and phage types of Salmonella enteric subspecies typhi and paratyphi in Christian Medical College and Hospital, Ludhiana, Punjab. J Indian Academy C Med 2007; 8: 32-35.
Chandel DS, Chaudhry R, Dhawan B, Pandey A, Dey AB. Drug-resistant Salmonella enterica Serotype Paratyphi A in India. Emer Infec Dis 2000; 6: 420-421. Anjum P, Qureshi A, Parvez M, Zahoor Ul Haq M, Hamid M. Increasing prevalence of multidrug resistant salmonella enterica serotype paratyphiA in patients with enteric fever. Pak J Med Res 2004; 43:56-59.
Hannan A, T Butt, Islam SN. First quinolone resistant typhoidal Salmonella. Pak Armed F Med J 1993; 44:27-30.
| Files | ||
| Issue | Vol 3 No 2 (2011) | |
| Section | Articles | |
| Keywords | ||
| Nalidixic acid resistance Therapeutic failure typhoid typhoidal Salmonella | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
